Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats

American Journal of Respiratory Cell and Molecular Biology

Volumn 24, Issue 2, 2001, Pages 101-107

  King, K A ^a   Hu, C ^a   Rodriguez, M M ^a   Romaguera, R ^a   Jiang, X ^a   Piedimonte, G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SYNCYTIAL VIRUS;

EID: 0035121922     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.24.2.4264     Document Type: Article

References (34)

1. Respiratory syncytial virus
2. The RSV-asthma link: The emerging story
3. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
4. Human respiratory syncytial virus produces prolonged alterations of neural control in airways of developing ferrets
5. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs
6. Characterization of CP-122,721: A nonpeptide antagonist of the neurokinin NK1 receptor
7. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
8. The tachykinin family of peptides and their receptors
9. Neuroregulation of pulmonary immune responses by vasoactive intestinal peptide and substance P
10. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways
11. The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescence
12. Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine, and by antigen challenge
13. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma
14. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons
15. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin
16. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus (RSV)
17. Tachykinin peptides, receptors, and peptidases in airway disease
18. Localization of tachykinin NK-1, NK-2, and NK-3 receptors in airways by immunohistochemistry
19. Some statistical methods useful in circulation research
20. T-lymphocyte subpopulations in bronchial lymphoid tissue of RSV-infected rats overexpress substance P receptors
21. Neurogenic inflammation in the rat trachea: I. Changes in venules, leucocytes, and epithelial cells
22. Synaptic relationship between substance P and substance P receptor: Light and electron microscopic characterization of the mismatch between neuropeptides and their receptors
23. Immunochemical localization of type I VIP receptor and NK-1-type substance P receptor in rat lung
24. Serious respiratory tract disease caused by respiratory syncytial virus: Prospects for improved therapy and effective immunization
25. Rhinoviruses
26. Neuropeptides in the respiratory tract
27. Role of peptidases in airway defense mechanisms
28. Coupling between inositol phosphate formation and DNA synthesis in smooth muscle cells stimulated with neurokinin A
29. Stimulation of connective tissue cell growth by substance P and substance K
30. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells
31. Antiinflammatory actions of VIP in the lungs and airways
32. Inhibition of human airway smooth muscle cell proliferation by vasoactive intestinal peptide (VIP)
33. Tachykinins activate guinea pig alveolar macrophages: Involvement of NK1 and NK2 receptors